Literature DB >> 12202542

Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b.

Zhenyu Chen1, Karen E Weck.   

Abstract

Although the 5' untranslated region (5' UTR) is the most conserved region of the hepatitis C virus (HCV) genome, it has been suggested that interrogation of this region is sufficient for determination of the HCV genotype. We compared two methods of determination of the HCV genotype: (i) direct sequencing of the DNA of the NS-5b region and (ii) reverse line probe assay (LiPA; INNO-LiPA HCV II; Innogenetics N.V.) of the 5' UTR. There was 100% concordance between the two methods for genotype but only 80% concordance for subtype. A significant percentage of genotype 1a isolates were misclassified by LiPA as genotype 1b. Sequence analysis revealed that the only consistent difference in the 5' UTR for these genotype 1a isolates misclassified as genotype 1b was a single nucleotide (A/G) at position -99 of the HCV genome. All isolates with discordant results analyzed had a G at this position, consistent with LiPA determination of these samples as subtype 1b. However, sequence analysis of 222 nucleotides in the NS-5b region clearly identified all of these isolates as subtype 1a. Population distribution data from the University of Pittsburgh Medical Center of over 200 samples analyzed by sequencing of the NS-5b region and over 1,000 samples analyzed by LiPA also indicated that INNO-LiPA HCV II cannot accurately differentiate HCV genotype 1a isolates from HCV genotype 1b isolates. We provide evidence that the A/G at position -99 represents a sequence polymorphism in the HCV genome that cannot differentiate subtype 1a from subtype 1b isolates. In conclusion, the 5' UTR is not heterogeneous enough for use in determination of the HCV subtype and cannot be used for differentiation of HCV genotypes 1a and 1b.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202542      PMCID: PMC130800          DOI: 10.1128/JCM.40.9.3127-3134.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection.

Authors:  G P Pageaux; J Ducos; A M Mondain; V Costes; M C Picot; P F Perrigault; J Domergue; D Larrey; H Michel
Journal:  Liver Transpl Surg       Date:  1997-09

2.  Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation.

Authors:  L S Belli; E Silini; A Alberti; G Bellati; C Vai; E Minola; G Rondinara; L de Carlis; M Asti; D Forti; G Ideo
Journal:  Liver Transpl Surg       Date:  1996-05

3.  There are two major types of hepatitis C virus in Japan.

Authors:  N Enomoto; A Takada; T Nakao; T Date
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

4.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test.

Authors:  J J Germer; P N Rys; J N Thorvilson; D H Persing
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Histological and clinical outcome after liver transplantation for hepatitis C.

Authors:  M C Shuhart; M P Bronner; D R Gretch; L V Thomassen; C F Wartelle; H Tateyama; S S Emerson; J D Perkins; R L Carithers
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

7.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

8.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

9.  Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

Authors:  G L Davis; R Esteban-Mur; V Rustgi; J Hoefs; S C Gordon; C Trepo; M L Shiffman; S Zeuzem; A Craxi; M H Ling; J Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

10.  Correlation between virus genotype and chronicity rate in acute hepatitis C.

Authors:  P Amoroso; M Rapicetta; M E Tosti; A Mele; E Spada; S Buonocore; G Lettieri; P Pierri; P Chionne; A R Ciccaglione; L Sagliocca
Journal:  J Hepatol       Date:  1998-06       Impact factor: 25.083

View more
  46 in total

1.  Comparison of 5' noncoding-core with 5' noncoding regions of HCV by RT-PCR: importance and clinical implications.

Authors:  Vikas Verma; Anita Chakravarti
Journal:  Curr Microbiol       Date:  2008-07-09       Impact factor: 2.188

2.  Rapid genotyping of hepatitis C virus by primer-specific extension analysis.

Authors:  Nick A Antonishyn; Vivian M Ast; Ryan R McDonald; Rabindra K Chaudhary; Lisa Lin; Anton P Andonov; Greg B Horsman
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Hepatitis C virus genotypes in clinical specimens tested at a national reference testing laboratory in the United States.

Authors:  Jeffrey J Germer; Jayawant N Mandrekar; Jordan L Bendel; P Shawn Mitchell; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2011-05-25       Impact factor: 5.948

Review 4.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

5.  Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping.

Authors:  Chen-Hua Liu; Cheng-Chao Liang; Chun-Jen Liu; Chih-Lin Lin; Tung-Hung Su; Hung-Chih Yang; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

6.  Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions.

Authors:  Elisa Martró; Victoria González; Andrew J Buckton; Verónica Saludes; Gema Fernández; Lurdes Matas; Ramón Planas; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

7.  Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.

Authors:  Pascal Veillon; Christopher Payan; Gastón Picchio; Michèle Maniez-Montreuil; Philippe Guntz; Françoise Lunel
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.

Authors:  Stéphane Chevaliez; Magali Bouvier-Alias; Rozenn Brillet; Jean-Michel Pawlotsky
Journal:  PLoS One       Date:  2009-12-08       Impact factor: 3.240

9.  Genotyping hepatitis C virus by heteroduplex mobility analysis using temperature gradient capillary electrophoresis.

Authors:  Rebecca L Margraf; Maria Erali; Michael Liew; Carl T Wittwer
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  HCV genotyping using statistical classification approach.

Authors:  Ping Qiu; Xiao-Yan Cai; Wei Ding; Qing Zhang; Ellie D Norris; Jonathan R Greene
Journal:  J Biomed Sci       Date:  2009-07-08       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.